CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International journal of nanomedicine, 2017 - Taylor & Francis
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International Journal of Nanomedicine, 2017 - search.proquest.com
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
[PDF][PDF] CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International Journal of Nanomedicine, 2017 - pdfs.semanticscholar.org
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.
N Hanagata - International Journal of Nanomedicine, 2017 - europepmc.org
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
[PDF][PDF] CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International Journal of Nanomedicine, 2017 - scienceopen.com
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International Journal of Nanomedicine, 2017 - dovepress.com
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International Journal of Nanomedicine, 2017 - go.gale.com
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
[HTML][HTML] CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International Journal of Nanomedicine, 2017 - ncbi.nlm.nih.gov
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
[引用][C] CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International Journal of Nanomedicine, 2017 - cir.nii.ac.jp
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious
diseases, and allergies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文 …
diseases, and allergies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文 …
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
N Hanagata - International journal of nanomedicine, 2017 - pubmed.ncbi.nlm.nih.gov
Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …
ODNs), which are synthetic agonists of Toll-like receptor 9 (TLR9), activate humoral and …